Up a level |
Pivot, Xavier and Pegram, Mark and Cortes, Javier and Luftner, Diana and Lyman, Gary H. and Curigliano, Giuseppe and Bondarenko, Igor and Ye Chan Yoon and Kim, Younsoo and Kim, Chul (2019) Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growthfactor receptor 2-positive breast cancer. European Journal of Cancer, V. 120. pp. 1-9. ISSN 0959-8049